Clinical Trials Logo

Urinary Tract Infections clinical trials

View clinical trials related to Urinary Tract Infections.

Filter by:

NCT ID: NCT03470584 Completed - Stroke Clinical Trials

Vegetarian Diet and Chronic Degenerative Diseases

Start date: March 1, 2005
Phase:
Study type: Observational

To investigate the prospective association between a vegetarian diet and chronic degenerative diseases in two cohorts of Taiwanese Buddhists

NCT ID: NCT03462160 Not yet recruiting - Clinical trials for Prevention of Urinary Tract Infections in Children

Effectiveness of Probiotics Prophylaxis of Urinary Tract Infections in Children

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The investigators aim to assess the effectiveness of prophylaxis of urinary tract infections in children with a probiotic containing Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1. It is formulated a hypothesis that a 3-months course of probiotic prophylasis is more effective than placebo.

NCT ID: NCT03447639 Terminated - Clinical trials for Urinary Tract Infections

Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal

Start date: March 29, 2018
Phase: Phase 4
Study type: Interventional

Over the last decade, there has been great emphasis on reducing the incidence of hospital-acquired infections, including catheter-associated UTI (CAUTI). This study will evaluate the effectiveness of Betadine irrigation solution (2% povidone-iodine) instilled into the bladder immediately prior to indwelling catheter removal to decrease the risk of subsequent bacteriuria, leading to decreased rates of NHSN defined CAUTI.

NCT ID: NCT03445312 Completed - Clinical trials for Urinary Tract Infections

Safety and Effectiveness of a Laboratory Intervention to Effectively NOT Treat Asymptomatic Bacteriuria

Salient
Start date: August 31, 2017
Phase:
Study type: Observational

This is an observational cohort study of 1000 consecutive patients on medical and surgical wards at the Mount Sinai Hospital in Toronto who have a mid-stream urine culture ordered. When these cultures are ordered or received in the laboratory, a message is posted that the specimen will not be processed in the laboratory unless a call is received to say that the patient has local urinary symptoms. The goal is to establish whether not processing mid-stream urine cultures is safe.

NCT ID: NCT03445195 Completed - Clinical trials for Acute Pyelonephritis

Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections

Start date: January 17, 2018
Phase: Phase 2
Study type: Interventional

This study is a double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of IV ETX2514SUL in patients with complicated urinary tract infections (cUTIs) who are otherwise relatively healthy.

NCT ID: NCT03425396 Completed - Cystitis Clinical Trials

Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis

Start date: January 4, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of oral omadacycline as compared to oral nitrofurantoin in the treatment of female adults with cystitis.

NCT ID: NCT03399682 Recruiting - Urinary Infection Clinical Trials

Incidence of Post Cystography Urinary Tract Infections in the Pediatric Population

IUCPED
Start date: January 3, 2018
Phase: N/A
Study type: Observational [Patient Registry]

Cystography is a frequent pediatric examination, although indications have been recently restricted . Current indications in our center are: - The occurrence of 2 episodes of acute pyelonephritis - or 1 episode of pyelonephritis if dilatation of the pelvic ureter> 5 mm for male children Urinary tract infections that occurred in the month following this test are considered secondary to cystography. However, no recent study has investigated the prevalence of urinary tract infections post cystography. There is no recent epidemiological data on this risk of infection, especially since the management of infections has changed and aseptic precautions during retrograde cystography have evolved with most of the time coverage. antibiotic. The main objective of this multi-center epidemiological prospective study is to perform a recent analysis of the retrograde post-cystographic urinary tract infection rate. Material and methods: Epidemiological, observational, multicenter, prospective study over a period from January 2018 to January 2019. No therapeutic modification will be undertaken at the end of the study. Parents will be called one months after the exam to check if their child had a urinary infection.

NCT ID: NCT03395288 Terminated - Clinical trials for Urinary Tract Infections

Nutraceutical Efficacy for rUTI

Start date: March 22, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This is a study designed to evaluate the efficacy of a nutraceutical as a non-antibiotic treatment to prevent recurrent urinary tract infections in women that have completed menopause and are on vaginal estrogen therapy. An additional group of women with recurrent urinary tract infections that have completed menopause but are not using vaginal estrogen therapy will be followed while taking the nutraceutical. The study length is ninety days from the date that the study participant will be instructed is day 1.

NCT ID: NCT03379389 Completed - Clinical trials for Urinary Tract Infections

Clinical Assessment of Urinary Antiseptics Methenamine and Methylthioninium in Recurrent Cystitis

Start date: March 31, 2018
Phase: Phase 4
Study type: Interventional

This is a double-blind, randomized, double-dummy, comparative study in parallel groups of subjects presenting with recurrent cystitis (≥2 episodes within the past 6 months). Subjects will be randomized and treated with one of two presentations of urinary antiseptics containing methenamine and methylthioninium for three days, followed by three days of antibiotic therapy as determined by urine culture and antibiogram. This study aims to assess the efficacy and safety of each treatment.

NCT ID: NCT03379194 Completed - Clinical trials for Urinary Tract Infections

Routine Antibiotic Prescription Monitoring in Primary Care Physicians: A Nationwide Trial

Start date: January 2, 2018
Phase: N/A
Study type: Interventional

Antibiotic resistance is an increasingly serious problem in Switzerland which is associated with the exposure and overall uptake of antibiotics in a population. Reduced antibiotic prescribing for outpatients is paralleled by a decrease in antibiotic resistance rates. In a recent pragmatic trial, the investigators found only promising yet not very conclusive results as those were present only in some groups. This nationwide antibiotic stewardship program with routine feedback on antibiotic prescribing was not associated with an overall change in antibiotic use. In older children, adolescents, and younger adults fewer antibiotics were prescribed, but not consistently over the entire intervention period. Hence, the investigators now aim to evaluate a better-tailored program to obtain a better understanding of the effects on patient-relevant outcomes, antibiotic resistance, and the underlying mechanisms leading to different effects in certain subgroups of patients. The investigators plan to evaluate a nationwide antibiotic stewardship program combining routine prescription feedback with the provision of physician and patient education material for primary care physicians in Switzerland. The project is conducted within the framework of the National Program on antimicrobial resistance by the Swiss National Science Foundation. Also, additional subprojects will be done where we will assess the impact of COVID-19 on AB prescription by comparing the years 2017,2018, and 2019 with the year 2020 data.